Clinical Study of XP-006 mRNA Vaccine for R/R B-NHL

Clinical trial NCT07334574 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07334574
Sponsor: Ruijin Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

B-cell Non-Hodgkin's Lymphoma (B-NHL)

Start date: 2026-01-15
Primary completion: 2028-01-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.